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1. Introduction 
One of the challenges that physicians taking care of children face is the interpretation of an 
electrocardiogram (ECG). The findings on ECG should be seen in the light of a patient’s 
clinical presentation. In this evidence-based chapter, we will explore the most common 
pediatric arrhythmias, including sinus arrhythmia, premature beats, brady-arrhythmias, 
escape rhythms and tachy-arrhythmias including different types of atrial, junctional and 
ventricular tachycardias. The objective of this chapter is to familiarize the reader with ECG 
interpretation of common pediatric arrhythmias in children and young adults. 
2. Sinus arrhythmia  
2.1 Definition: Sinus arrhythmia is the normal variation in the rate of the sino-atrial (SA) 
node that is mainly associated with the respiratory phases.  
2.2 Incidence: It is common in children and the incidence decreases with age(Kaushal and 
Taylor 2002). 
2.3 Mechanism: It occurs due to change in sinus node function related to changes in the 
autonomic tone. Inspiration and expiration are associated with increased and decreased 
heart rate due to decreased and increased parasympathetic tone, respectively(Coker et al. 
1984). Sinus arrhythmia disappears with conditions associated with elevated sympathetic 
tone causing increased heart rate.  
2.4 Clinical presentation: Auscultation reveals irregular heart rhythm which varies with 
respiration.  
2.5 ECG: ECG reveals sinus rhythm with variation in P-P interval preceding the change in R-
R intervals without any significant change in P-R interval (Figure 1).  
2.6 Management: No work-up is needed because sinus arrhythmia is a normal variant with 
excellent prognosis. 
3. Ectopic complexes (premature beats) 
3.1 Premature atrial contractions 
3.1.1 Definition: Premature atrial contraction (PAC), or atrial premature beat, is a premature 
discharge arising from an atrial focus other than the sino-atrial (SA) node. 
3.1.2 Incidence: PACs were reported in 14% of full-term infants on 24-hour ECGs (Southall et 
al. 1980). Among 10-13 year old boys with healthy hearts, 13% had singlet PACs (Scott et al. 
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Fig. 1. Sinus arrhythmia 
1980). On 24-hour ECG monitoring, 64% of young women (Sobotka et al. 1981) and 56% of 
male adolescents had PACs (Brodsky et al. 1977). Frequent causes of PACs include intake of 
caffeine, nicotine, alcohol, and other stimulants. PACs can be associated with atrial 
enlargement, electrolyte abnormalities, mechanical trauma, chronic pulmonary disease, and 
heart failure.  
3.1.3 Mechanism: PACs can occur either due to a re-entry mechanism, (Wallace and Daggett 
1964) automaticity outside of the SA node, or triggered activity (Wit and Cranefield 1977).  
3.1.4 Natural history: PACs can give rise to atrial fibrillation and flutter, especially in older 
post-operative patients(Jideus et al. 2006). They may subside with removal or correction of 
the inciting stimuli. Control of congestive heart failure, ischemic heart disease, pulmonary 
disease, and electrolyte abnormalities may decrease the incidence of PACs.  
3.1.5 Clinical presentation: Patients with PACs may be asymptomatic or perceive them as 
palpitations. They may be incidentally detected as irregular heart rhythm on auscultation. 
3.1.6 ECG: A PAC presents as a P-wave that appears earlier than expected on an ECG. The 
P-wave morphology may appear different. The PR interval in a PAC is often different than 
the previous PR interval. PACs can have three possible outcomes: 1) block at the AV node 
due to AV nodal refractoriness (Figure 2a), 2) conduct normally through the AV node 
(Figure 2b), or 3) conduct with aberrancy due to His-bundle refractoriness (Figure 2c). There 
is no compensatory ventricular pause. 
3.1.7 Work-up: A 12-lead ECG is usually adequate for evaluation; however, Holter 
monitoring may be performed. 
3.1.8 Management and Prognosis: Control of exogenous factors will decrease the incidence of 
PACs. No physical restrictions need to be imposed on children without heart and/or lung 
disease, or electrolyte abnormalities. Beta blocker like bisoprolol decreased PACs by 50%, 
although 25% of these patients had adverse reactions associated with beta blockade 
(Sugimoto et al. 1986). Prognosis is excellent for patients with PACs with normal hearts and 
needs no treatment. 
 
 
Fig. 2.a Premature atrial complex that is blocked 
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Fig. 2.b Premature atrial complex that is normally conducted 
 
Fig. 2.c Premature atrial complex that is conducted with aberrancy 
3.2 Premature ventricular contractions 
3.2.1 Definition: A premature ventricular contraction (PVC) or ventricular premature beat 
(VPB) is an early ventricular beat that originates below the bifurcation of the bundle of His. 
It is characterized by a premature wide QRS complex that is morphologically different 
compared to the baseline QRS complexes (Sherron et al. 1985; Olgin and Zipes 2005b). 
3.2.2 Incidence: PVCs follow a bi-modal distribution and are seen in 18% of neonates, 20% of 
toddlers, 16% of school children, 20-30% of adolescents and subsequent increases in late 
adulthood (Southall et al. 1980). On 24-hour ECG monitoring of subjects without heart 
disease, 54% of young women (Sobotka et al. 1981) and 50% of young males had PVCs 
(Brodsky et al. 1977). Surgically-corrected Tetralogy of Fallot patients have an incidence of 6-
48% (Vaksmann et al. 1990),(Chandar et al. 1990). 
3.2.3 Mechanism: Three mechanisms inducing PVCs include: automaticity, re-entry, and 
triggered activity. PVCs can result from mechanical, electrical, and chemical stimulation 
leading to ventricular depolarization. Abnormalities in metabolism, electrolytes, or 
iatrogenic causes can initiate PVCs in children. Both slow and fast heart rates are associated 
with PVCs (Sherron et al. 1985). 
3.2.4 Natural history: PVCs increase with age and are more common in males (Silka and 
Garson 1999). In the absence of heart disease, PVCs are inconsequential under the age of 30 
years but influence risk of sudden death in those over 30 years (Chiang et al. 1969). PVCs 
may be present in those with increased vagal tone such as athletes or in those with increased 
stimulation such as intake of caffeine, alcohol, and/or nicotine. In adults without structural 
heart disease, PVCs induced during exercise and recovery phases were associated with 
increased risk of mortality (Frolkis et al. 2003). PVCs also occur in those with surgically-
corrected congenital heart disease, myocarditis, right-ventricular dysfunction, congestive 
heart failure, cardiomyopathy, ventricular hypertrophy, myocardial infarction, ventricular 
non-compaction and iatrogenic causes (Chandar et al. 1990; Vaksmann et al. 1990; Espinola-
Zavaleta et al. 2006; Sestito et al. 2007).  
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3.2.5 Clinical presentation: PVCs are the most common cause of irregular heart beats in 
children. They are usually detected incidentally and occasionally produce symptoms. Single 
PVCs are generally well-tolerated by children. Symptoms secondary to PVCs include 
palpitations, lightheadedness, fatigue, chest pain, and shortness of breath.  
3.2.6 ECG: To be classified as PVC, four criteria should be met: 1) premature QRS without a 
premature P wave, 2) difference in QRS morphology between PVC and regular QRS 
complex, 3) prolonged QRS duration for age, and 4) different QRS and T wave vectors. 
Unifocal PVCs have a fixed morphology, as opposed to PACs with aberrant conduction. 
Multifocal PVCs have different morphologies due to the different locations of onset and 
electrical instability of the ventricle (Silka and Garson 1999). There is a compensatory pause 
after PVC, i.e., R-R interval produced by SA node initiated QRS complexes on either side of 
the PVC is equal to twice the normal R-R interval (figure 3). PVCs may present as isolated, 
couplets, bigeminy or trigeminy pattern. If the PVC originates in the right ventricle, the QRS 
morphology appears as a left bundle branch block pattern and if the PVC originates in the 
left ventricle, the QRS morphology appears as a right bundle branch block pattern. 
3.2.7 Differential diagnoses: 1) Premature atrial complex with aberrant conduction, 2) 
premature junctional complex with aberrant conduction, and 3) anterograde conduction 
over an accessory pathway with pre-excitation. 
 
 
Fig. 3. Premature ventricular complex with a compensatory pause  
3.2.8 Work-up: A detailed history of episodes is necessary. A history of congenital heart disease 
with subsequent surgical correction should be obtained. In addition to an ECG and 24-hour 
Holter monitoring, an exercise test is important in determining whether the frequency of PVCs 
or symptoms worsen with activity (Paridon 2006; Zipes 2006). Multifocal PVCs in structural 
heart disease require further workup. Echocardiography and electrophysiology studies may 
be warranted in surgically corrected patients or those with structural heart disease if there are 
PVCs and malignant ventricular arrhythmias (Case 1999). 
3.2.9 Management and Prognosis: Management of PVCs depends on two factors: 1) a history of 
structural heart disease or surgically corrected congenital heart disease, and 2) the 
symptoms experienced by the patient. In children, PVCs are considered to be benign if they 
disappear with exercise (Attina et al. 1987). The majority of children with normal hearts 
presenting with asymptomatic single PVC, bigeminy, or trigeminy do not require treatment. 
Given that surgically-corrected congenital heart disease is associated with increased 
predisposition to non-sustained ventricular tachycardia and sudden cardiac death, children 
may require treatment with anti-arrhythmics under the supervision of a pediatric 
cardiologist. Beta-blockers can assist in suppressing PVCs in symptomatic patients 
(Alexander 2001a). If symptoms are not medically controlled, catheter ablation is an option 
(Zhu et al. 1995). Prognosis depends on whether there is underlying structural and 
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metabolic heart disease. PVCs inducible during exercise can be ominous in patients with 
structural heart disease and are of higher significance (Silka and Garson 1999). Athletes with 
structural heart disease in high-risk groups with PVCs should be restricted to low-intensity 
sports (Zipes and Garson 1994). 
3.3 Premature junctional complexes 
3.3.1 Definition: A premature junctional complex (PJC) or beat (PJB) is a premature discharge 
that originates in the AV junction either at the level of the AV node or the bundle of His, in 
the absence of a preceding atrial discharge. 
3.3.2 Incidence: PJCs can occur in structurally normal or abnormal hearts and in all age 
groups. The incidence and prevalence are not well known. Among 16-19 year old males, 
0.21% had premature junctional complexes on 12-lead ECG and similar in other age groups 
(Hiss and Lamb 1962). 
3.3.3 Mechanism: PJCs arise due to increased automaticity or triggered activity due to after 
depolarizations within the AV junction (Hoffman and Cranefield 1964; Rosen et al. 1980). 
PJCs may predispose the patient to ventricular tachycardia. Potential causes include normal 
variants, use of stimulants or alcohol, hypokalemia, hypoxemia, ischemia, and digitalis 
toxicity (Sherron et al. 1985). 
3.3.4 Clinical presentation: It may be incidentally detected or may produce symptoms like 
palpitations, syncope, or dizziness.  
3.3.5 ECG: ECG shows QRS complex morphology similar to sinus node originated 
activation, without preceding P-wave. A PJC conducting to the ventricle with aberrancy has 
a QRS complex comparable to PVC. A retrograde P-wave may appear before, during, or 
after the QRS complex (Sherron et al. 1985) (Figure 4).  
3.3.6 Work-up: Depending on the frequency of the PJCs, an ECG can identify the premature 
complexes. If unsuccessful, a 24-hour Holter monitor may be used. An electrophysiology 
study maybe needed to identify the location of the origin of the PJCs; origin distal to the AV 
node can initiate ventricular tachycardia (Sherron et al. 1985). 
3.3.7 Management and Prognosis: Patients with PJCs are usually left untreated. The 
management of underlying causes is essential to decrease symptomatic PJCs. If symptoms 
are severe, medical management and pacing may be warranted to increase the heart rate.  
 
 
Fig. 4. Premature junctional complex 
4. Bradyarrhythmias 
4.1 Sinus node dysfunction (SND) 
4.1.1 Definition: The inability of the sino-atrial (SA) node to discharge/activate (sinus 
pause/arrest) or inappropriately activate (tachycardia-bradycardia syndrome) the atrial tissue. 
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4.1.2 Incidence: SND is relatively uncommon in children with normal cardiac anatomy and 
the exact incidence is unknown. However, it is a common problem in those who have had 
surgery for congenital heart disease (CHD), especially in patients with Mustard, Senning, 
and Fontan procedures (Fishberger 2001). Approximately 2/3 of all immediate post-
transplant patients have SND (Jacquet et al. 1990). 
4.1.3 Mechanism: In sinus node pause/arrest, there is a lack of discharge from the SA node; 
causing no activation of the atria. With sinus node exit block, the activation may be delayed 
significantly or blocked completely at the nodal region, without activation of the atria. In 
tachycardia-bradycardia syndrome, severe sinus bradycardia is followed by tachycardia in 
the form of atrial flutter in the pediatric population and atrial fibrillation/flutter in adults 
with repaired congenital heart disease (Duster et al. 1985; Gelatt et al. 1994).  
4.1.4 Natural history: Sinus node dysfunction may present as severe sinus bradycardia, sinus 
pause or arrest, periods of junctional rhythm, and/or alternating tachycardia-bradycardia 
periods. Sinus node dysfunction increases in frequency with age of the patient and time 
from surgery. 
4.1.5 Clinical presentation: It depends on the age, underlying cardiac conduction abnormality, 
and hemodynamic status. Although majority of children with structurally normal hearts 
remain asymptomatic; fatigue, exercise intolerance, palpitations, chest pain, dizziness, and 
syncope may occur (Fishberger 2001). These symptoms are more frequent in those with 
corrected congenital heart disease. Infants present with poor feeding, lethargy or heart 
failure. Sudden death is an uncommon presentation. 
4.1.6 ECG: ECG may show severe sinus bradycardia, sinus pause, junctional rhythm, and/or 
atrial fibrillation/flutter. Due to the short duration, significant episodes can be missed. 
4.1.7 Work-up: Non-invasive testing includes a 12-lead ECG, a Holter monitor, an event 
monitor and exercise stress test. Depending on the frequency of the symptoms and the age 
group, a 24-hour Holter monitor can be employed. In an older age group with less frequent 
symptoms, an event recorder can be used to record rhythm abnormalities. In patients who 
are able to exercise, a treadmill stress test will show lower heart rate response to maximal 
exercise and rapid decrease in heart rate during recovery time immediately after the test 
(Martin and Kugler 1999; Fishberger 2001). Intrinsic heart rate (IHR) is the heart rate with 
complete blockade of autonomic activity with atropine and propranolol (Jose AD and 
Collison D, 1970). Normal value of IHR is defined as 118.1 – (0.57 x age). The intrinsic heart 
rate decreases with age in complete autonomic blockade but decreases at a faster rate in 
patients with SND (Benditt et al. 1984). In invasive testing, an electrophysiology study is 
undertaken to evaluate sinus node automaticity, and conduction time. Sino-atrial 
conduction time (SACT) and sinus node recovery time (SNRT) are assessed with premature 
atrial stimulation and atrial overdrive pacing, respectively. The length of SNRT evaluates 
the sinus node automaticity; prolongation of SNRT indicates suppression of sinus node 
automatic function. 
4.1.8 Management and Prognosis: Medical treatment is dependent on the type of sinus node 
dysfunction and the presence of associated symptoms. Choice of medications should be 
selected cautiously and the patient should be monitored closely.  
1. Sinus bradycardia and pause/arrest < 3 sec: no further management; pause/arrest > 3 
sec requires evaluation. In severe sinus bradycardia with hemodynamic instability, 
sympathomimetic drugs such as atropine and isoproterenol or transcutaneous pacing 
are used.  
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2. Tachycardia-Bradycardia syndrome management is difficult. Drugs used to manage 
tachycardia may worsen sinus bradycardia and should be used judiciously and may 
necessitate cardiac pacing. 
With failed medical therapy and the need for long-term anti-arrhythmic medications, 
pacemaker implantation is indicated. According to the 2002 ACC guidelines for pacemaker 
implantation (Gregaratos 2002), documented symptomatic bradycardia (Class I), 
symptomatic chronotropic incompetence (Class I), syncope of unknown etiology with 
electrophysiologic studies suggestive of SND (Class IIa), and chronic awake heart rate < 40 
(Class IIb) are primary indicators for permanent pacing. Permanent pacing is indicated in 
bradycardia-tachycardia (Class IIa). In refractory or symptomatic SND patients who have 
failed medical therapy, permanent pacemaker implantation improves clinical status. 
Pacemaker implantation can provide anti-bradycardia pacing in severe bradycardia; in 
tachycardia-bradycardia syndrome, pacemaker can provide anti-tachycardia and anti-
bradycardia pacing.  
4.2 First-degree atrio-ventricular heart block 
4.2.1 Definition: Delay in atrio-ventricular conduction at the level of the atrial tissue, AV 
node, and/or the His-Purkinje system. 
4.2.2 Incidence: First degree AV block has been detected in 6% of neonates (Ferrer 1977). 
Among 10-13 year old males, 8.5% had first degree heart block (Scott et al. 1980).  
4.2.3 Mechanism: Common mechanism in pediatric patients is hypervagotonia. However, 
other causes include medications which prolong AV-node refractory period, electrolyte 
abnormalities, hypothermia, hypothyroidism, rheumatic fever, myocarditis, Lyme disease, 
congenital heart disease that stretches the atria at the AV node area, cardiac surgery, and 
myopathies (Weindling 2001). Four sites for first degree AV block with a normal QRS 
include: atrium (3-20%) (Sherron et al. 1985), AV node (35-90%) (Sherron et al. 1985), Bundle 
of His (15%) (Sherron et al. 1985) and infra-Hisian conduction system. It is more common in 
endocardial cushion defects and Ebstein’s anomaly of the tricuspid valve due to intraatrial 
conduction delay (Sherron et al. 1985). Increased vagal tone, calcium-channel blockers, 
digoxin, and beta-blockers are common causes of AV nodal delay. Quinidine, procainamide, 
and disopyramide impair phase 0 depolarization and cause delay in bundle of His 
conduction. Finally, prolongation of conduction in the infra-Hisian region can be caused by 
sodium-channel blockers as above. With first degree AV block with a wide QRS complex, 
conduction in the AV node or the bundle of His is delayed; bilateral bundle branch 
conduction is slowed in most cases; two levels of conduction delay can also be seen (Peuch 
et al. 1976). 
4.2.4 Natural history: First degree heart block has the potential, although rarely, to progress 
to higher-degree heart blocks in myocarditis, and adults with ischemic heart disease. In a 30-
year follow up of adult males with moderate P-R interval prolongation, first degree heart 
block was benign (Mymin et al. 1986).  
4.2.5 Clinical presentation: Patients with first degree AV block are asymptomatic unless 
associated with significant left ventricular (LV) dysfunction. Marked prolongation of the PR 
interval can cause symptoms mimicking pacemaker-like syndrome. 
4.2.6 ECG: There is prolongation of PR interval beyond the normal ranges for age. Normal P-
R interval naturally varies with age in the pediatric population and prolongation of the P-R 
interval should be viewed in this context (Figure 5). 
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4.2.7 Work-up: An ECG can detect first degree block with or without infranodal disease 
based on QRS pattern. Atropine and exercise stress testing decrease the vagal tone and 
enhance AV nodal conduction, thereby shortening the PR interval. If the delay is due to 
infranodal disease, the conduction delay is worsened. Electrophysiology study can be used 
to determine the site of conduction delay.  
4.2.8 Management and Prognosis: Family history of rhythm or connective tissue disease 
should be obtained. Repeat ECGs are indicated in those with suspected progression to 
higher grade blocks. Indications for a pacemaker include first degree block with symptoms 
suggestive of a pacemaker-like syndrome (Class IIa), and presence of first degree block in 
neuromuscular diseases and LV dysfunction (Class IIb) (Gregaratos 2002). 
 
 
Fig. 5. First degree AV block 
4.3 Second-degree atrio-ventricular heart block 
4.3.1 Definition: Second-degree heart block is atrio-ventricular block in which some atrial 
discharges are not conducted to the ventricles. It is classified as Mobitz type I (Wenckebach 
phenomena), Mobitz type II and high grade.  
4.3.2 Incidence: Wenckebach phenomena was detected in 2% of infants, 7% of toddlers and 
6% of children at rest (von Bernuth et al. 1989).  
4.3.3 Mechanism: Mobitz type I (Wenckebach) block occurs at the AV node and His-Purkinje 
system in a ratio of 3:1, respectively (Peuch et al. 1976). Wenckebach phenomenon results from 
hypervagotonia in athletes and young subjects (Stein et al. 2002). Previous cardiac surgery and 
ischemic heart disease in adulthood are associated with Wenckebach phenomena. Mobitz type 
II block occurs infra-nodally in most cases (Dhingra et al. 1974).  
4.3.4 Natural history: Mobitz type I block is usually benign. However, in pediatric population 
without heart disease, Mobitz type I block may serve as intermediary prior to development 
of idiopathic complete heart block (Young et al. 1977). In adults, second degree AV-nodal 
block proximal to the His bundle has a benign course in those without heart disease; but is 
associated with poor prognosis in those with underlying heart disease (Strasberg et al. 1981). 
Mobitz type II can progress to symptomatic complete heart block and is associated with 
Stokes-Adams attacks and sudden death (Dhingra et al. 1974).  
4.3.5 Clinical presentation: Mobitz type I block is usually well tolerated; but may present with 
significant bradycardia. Patients with Mobitz type II block may be asymptomatic; but can 
present with bradycardia, exercise intolerance, syncope, postural hypotension, and sudden 
death. 
4.3.6 ECG: Mobitz type I shows progressive prolongation of PR interval followed by a non-
conducted atrial discharge (Figure 6a). Mobitz type II is characterized by stable PR interval 
with intermittent failed conduction (Figure 6b). PR interval can be normal or prolonged. 
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4.3.7 Work-up: ECG is diagnostic. If ECG is inconclusive, a 24-hour monitor is suggested. If 
there is one conducted beat in a cycle as in a 2:1 block, it is difficult to differentiate between 
Mobitz types I and II blocks; atropine can be used to elicit a 3:2 conduction in Mobitz type I 
block. Response to atropine suggests the block to be at or proximal to the AV node. If 
exercise initiates or exacerbates Mobitz type I block, infranodal location of the block is 
suspected. An electrophysiology study is indicated if there is unexplained syncope, and AV 
block distal to the AV node, to identify the location of the block (Zipes et al. 1995). In 
complete or high grade second degree AV block, an echocardiogram is indicated (Cheitlin et 
al. 2003).  
4.3.8 Management: Medical management of Mobitz type I includes identification and 
treatment of underlying causes. Sympathomimetic agents such as scopolamine, 
theophylline, or glycopyrrolate can be used in symptomatic bradycardia secondary to 
increased vagal tone. In patients with Mobitz type II, syncope is a poor prognostic factor 
(Dhingra et al. 1974). Symptomatic chronic bradycardia in Mobitz type I and type II (Class I), 
Mobitz type II with bifascicular or trifascicular block (Class I), Mobitz type II with wide QRS 
(Class I), asymptomatic Mobitz type II (Class IIa), and neuromuscular disease with AV block 
(Class IIb) are all indications for permanent pacemaker implantation (Gregaratos 2002).  
 
 
Fig. 6.a Second degree Type I AV block (Wenckebach) 
 
 
Fig. 6.b Second degree Type II (Mobitz) AV block 
4.4 Third-degree (Complete) Atrio-Ventricular Heart Block 
4.4.1 Definition: Complete failure of conduction of atrial impulses to the ventricles. 
4.4.2 Incidence: Complete heart block may be acquired or congenital. The most common 
cause of acquired complete heart block in pediatric patients is surgery for left ventricular 
outflow tract obstruction, repair of corrected transposition of the great arteries (L-TGA), 
ventricular septal defects and TOF. Acquired complete AV block is also seen in Lyme 
carditis, myocarditis, myopathies, and metabolic diseases. Congenital complete heart block 
occurs 1 per 15,000 to 1 per 22,000 live births and is often associated with maternal 
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connective tissue disease, in particular systemic lupus erythematosis (Michaelsson and 
Engle 1972). Spontaneous complete heart block is seen in left atrial isomerism, endocardial 
cushion defects and in 20% of patients with L-TGA (Huhta et al. 1983; Lundstrom et al. 
1990).  
4.4.3 Mechanism: Possible mechanisms include abnormal development of the conduction 
system and the AV node, or acquired most commonly after cardiac surgery. The escape 
rhythms below the AV node take over when the atrial discharge is not conducted to the 
ventricles. The rate of the escape rhythm correlates with the level of the block, with the 
proximal sites having a higher rate. 
4.4.4 Natural history: Complete heart block is associated with L-TGA and septal defects, as 
well as sequelae of maternal connective tissue. Mortality is highest during the neonatal 
period (Roberts and Gillette 1977). Congenital complete heart block in structurally normal 
heart, when uncorrected, leads to cardiac enlargement with impaired ventricular systolic 
function (Beaufort-Krol et al. 2007). There is a significant correlation between persistent 
heart rate of 50 or less and incidence of syncope, pre-syncope, and/or sudden death 
(Karpawich et al. 1981; Dewey et al. 1987).  
4.4.5 Clinical presentation: Many patients are asymptomatic in early life. Symptoms range 
from none to palpitations, chest pain, weakness, syncope, exercise intolerance, dizziness, 
and congestive heart failure in congenital complete heart block. Symptoms are usually 
dependent on ventricular rate, frequency of premature ventricular beats, and atrio-
ventricular synchrony.  
4.4.6 ECG: Complete heart block is depicted by atrio-ventricular conduction blockade. In 
patients with normal hearts, the QRS complex is narrow if the block is at the AV node or His 
bundle; the QRS complex is wide if the block occurs after the bifurcation of the bundle of 
His (Weindling 2001). An ECG should be used to differentiate complete heart block from 
accelerated junctional rhythm or severe sinus bradycardia with appropriate junctional 
escape rate (Weindling 2001). Complete heart block is associated with a prior lesser-degree 
block (25%) and accompanied or preceded by bundle branch block (Levine et al. 1956). 
Associated prolongation of QT interval is seen in about 18% of congenital complete heart 
block (Figure 7). 
4.4.7 Work-up: A 12-lead ECG establishes the diagnosis. In symptomatic patients treated with 
a pacemaker and with a suspicion of another arrhythmia (Class I), and patients with 
premature, concealed junctional depolarizations as in pseudo-AV block (Class II), an 
electrophysiology study is indicated (Zipes et al. 1995). In patients with complete AV block 
or advanced second-degree AV block, an echocardiogram is used to visualize cardiac 
function, size, structure, and valvular regurgitation (Cheitlin et al. 2003; Beaufort-Krol et al. 
2007). Exercise stress testing in asymptomatic patients with congenital complete heart block 
is used to determine degree of exercise tolerance and arrhythmias associated with exercise 
(Gibbons et al. 2002). 
4.4.8 Management and Prognosis: Primary mode of management of patients with complete 
heart block is pacemaker implantation. The time of pacemaker implantation is controversial. 
Third degree AV block with symptomatic bradycardia, post-operative complete heart block 
that does not resolve in 7-10 days, and congenital complete heart block with wide QRS 
escape rhythm and ventricular dysfunction, and congenital complete heart block with rate 
<50 bpm are Class I indications for pacemaker implantation (Gregaratos 2002). Prognosis for 
neonates and infants post pacemaker implantation is very good (Aellig et al. 2007).  
www.intechopen.com
 
Arrhythmias in Children and Young Adults 
 
51 
 
Fig. 7. Third degree (complete) AV block 
4.5 Atrial escape rhythm 
4.5.1 Definition: Atrial escape rhythm arises from ectopic atrial foci during periods of severe 
sinus bradycardia or significant sinus node dysfunction. These atrial ectopic foci have 
slower spontaneous rates and are unstable. The exact incidence of atrial escape rhythm is 
not known 
4.5.2 Mechanism: The automaticity of an ectopic atrial focus generates a faster rate than the 
dysfunctional sinus node by escaping overdrive suppression of the SA node. Atrial escape 
rhythm rate is between 60-80 beats per minute (Dubin 2000). 
4.5.3 Natural history: Atrial escape rhythm occurs in sinus node dysfunction and severe sinus 
bradycardia. Resolution or treatment of a slow underlying sinus rhythm resolves the atrial 
escape rhythm. Automaticity in ectopic foci are more responsive to autonomic control 
compared to the SA node (Randall et al. 1981). 
4.5.4 Clinical presentation: Most symptoms are secondary to underlying rhythm abnormalities 
such as sinus node dysfunction with severe sinus bradycardia, sinus pause and/or sinus 
arrest. These include dizziness, exercise intolerance, and possible syncope. 
4.5.5 ECG: The P-wave morphology differs from the sinus P-wave. The P-wave is smaller 
and shorter in duration with the P-wave axis dependent on the location of the ectopic focus. 
The PR interval may be shorter than the normal PR interval due to the proximity of the 
ectopic atrial focus to the AV node. The atrial escape rhythm is slower than the normal sinus 
rate.  
4.5.6 Work-up: Work-up is focused on identifying the underlying abnormality leading to 
increased automaticity or suppression of the sinus node. 
4.5.7 Management and Prognosis: In symptomatic patients, slow sinus rhythm is managed 
with sympathomimetic agents. If unresponsive to medical treatment, pacemaker 
implantation may be necessary for management of sinus node dysfunction or severe sinus 
bradycardia. 
4.6 Atrio-ventricular junctional escape rhythm 
4.6.1 Definition: AV junctional escape rhythm is defined as an ectopic rhythm starting in the 
AV junction due to failure of the atrial impulse to conduct. The ectopic rhythm may 
originate between the AV node and the bundle of His.  
4.6.2 Incidence: Episodes of junctional escape rhythm were reported in 19% of full-term 
neonates (Southall et al; Southall et al. 1980). 
4.6.3 Mechanism: AV junctional escape rhythm occurs due to enhanced automaticity or a 
reentry mechanism. The ectopic focus can occur below the AV node and at or above the 
bundle of His, in the absence or suppression of an SA node or atrial impulse (Gamble et al. 
2007). Due to the lack of overdrive suppression from the higher pacemakers, the AV 
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junction has its intrinsic automaticity. The junctional escape rate ranges between 40-60 beats 
per minute (Dubin 2000). 
4.6.4 Natural history: The junctional pacemaker can exist in the region of the distal AV node 
or the proximal portion of the His-bundle near the AV-node (Alison et al. 1995). Nodal 
escape rhythm is associated with apnea (Valimaki and Tarlo 1971). The rate of AV junctional 
escape rhythm varies with underlying conditions, such as sick sinus syndrome, complete 
heart block, ablation of AV node, congenital heart surgery, hypertrophic cardiomyopathy, 
and ischemia (Kleinfeld and Boal 1978; Alison et al. 1995; Shepard et al. 1998). Inflammation, 
hypoxia, metabolic, drugs, or electrolyte disturbances are implicated in the etiology of 
junctional rhythms (Fisch and Knoebel 1970). 
4.6.5 Clinical presentation: Symptoms pertaining to AV junctional escape rhythm are related 
to suppression of the sino-atrial tissues and or failure to conduct to the junction. Symptoms 
include dizziness, exercise intolerance, near syncope or syncope. 
4.6.6 ECG: In AV junctional escape rhythm, there are no P-waves before the QRS complexes; 
they may occur simultaneously or follow the QRS complexes. The QRS complex is narrow if 
the focus is closer to the AV node or wide if proximal to the His bundle bifurcation. In the 
case of complete AV block, P-waves of sinus origin are dissociated from the QRS complexes. 
4.6.7 Work-up: ECG may identify the rhythm; if unsuccessful, a Holter monitor can help 
identify the rhythm abnormality. Workup should also include identifying the causes listed 
above. 
4.6.8 Management and Prognosis: Pacemaker implantation may be needed in symptomatic 
bradycardia due to junctional escape rhythm. 
4.7 Idioventricular escape rhythm 
4.7.1 Definition: Ventricular escape (idioventricular) rhythm arises below the bifurcation of 
the His bundle. The ventricular escape results when the higher pacemaker systems are 
unable to generate and/or conduct an impulse to the ventricles. It is rare and incidence is 
not known. 
4.7.2 Mechanism: The automaticity of the ventricular myocardium is pronounced in the 
absence of supraventricular impulses. The overdrive suppression from higher pacemaker 
centers is absent, leading to the automaticity of the ventricular focus to conduct to the 
ventricles. Idioventricular rate ranges from 20-40 beats per minute (Dubin 2000). 
4.7.3 Natural history: Idioventricular rhythm is seen with hypothermia, drugs, and ischemia 
(Talbot and Greaves 1976).  
4.7.4 Clinical presentation: Stokes-Adams syncopal attacks are more prevalent in ventricular 
escape rhythm than atrial or junctional escape rhythms. This is also accompanied by 
dizziness and exercise intolerance. 
4.7.5 ECG: The ECG shows wide QRS complexes with a rate of 20-40 beats per minute. If P-
waves exist, they occur independently and are dissociated from the ventricular beats. 
4.7.6 Work-up: ECG is the first step in diagnosing ventricular escape rhythm. Holter and 
event recorders are alternatives when ECG is not diagnostic. Electrophysiology study is 
indicated (class IIA) in patients with suspected bradyarrhythmias with syncope (Zipes 
2006). An EP study can establish the level of the AV block. 
4.7.7 Management and Prognosis: Symptomatic relief is important in patients with ventricular 
escape rhythm. Pacemaker implantation with ventricular pacing is essential to avoid Stokes-
Adams attacks. 
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5. Tachy-arrhythmias 
5.1 Atrial tachy-arrhythmias 
5.1.1 Physiologic (appropriate) sinus tachycardia 
5.1.1.1 Definition: Sinus tachycardia is an automatic rhythm characterized by rapid discharge 
from the sinus node due to physiologic influences (Walsh 2001b; Blomstrom-Lundqvist et al. 
2003; Blomstrom-Lundqvist 2003). The rate of sinus tachycardia is dependent on age. 
5.1.1.2 Incidence: Dependent on the body’s increased sympathetic response to physiologic 
phenomena, such as fever, dehydration, anxiety, pain, medications, anemia, hyperthyroidism 
and heart failure.  
5.1.1.3 Mechanism: Occurs due to increased automaticity with rate variability associated with 
increased sympathetic response or vagal withdrawal. 
5.1.1.4 Natural history: Decreasing the underlying enhanced sympathetic tone or increasing 
the vagal tone will decrease the sinus tachycardia. 
5.1.1.5 Clinical presentation: The inciting factor for sympathetic response or vagal withdrawal 
is the usual presenting symptom. Very high rate of sinus tachycardia can compromise 
cardiac output by decreasing the ventricular filling time.  
5.1.1.6 ECG: There is a normal P-wave axis and a P-wave precedes each QRS complex (Van 
Hare 1999). P-waves may have larger amplitude and become peaked (Blomstrom-Lundqvist 
2003). 
5.1.1.7 Work-up: Identify the extrinsic factors causing the tachycardia and treat them. It is 
also necessary to rule out inappropriate sinus tachycardia (see below).  
5.1.1.8 Management and Prognosis: Prognosis depends on the nature of the underlying cause. 
No specific treatment is required for physiologic sinus tachycardia except treatment of the 
underlying causes. Beta-adrenergic receptor blockers may occasionally be used for 
treatment of physiologic symptomatic sinus tachycardia (Blomstrom-Lundqvist 2003). 
5.1.2 Inappropriate Sinus Tachycardia (IST) 
5.1.2.1 Definition: Elevated resting heart rate for the physiological state and/or an exaggerated 
heart rate response to exercise or stress (Krahn et al. 1995; Blomstrom-Lundqvist 2003).  
5.1.2.2 Incidence: IST often follows a viral illness or physical trauma, usually in women (90%) 
who are generally healthy physically and emotionally (Fogoros 2006). 
5.1.2.3 Mechanism: Etiology is not known. The mechanism may involve a primary sino-atrial 
(SA) node disorder with increased automaticity, a dysautonomia with increased 
sympathetic tone, decreased parasympathetic tone, and/or increased SA node beta-
adrenergic sensitivity, or impaired baroreflex control (Krahn et al. 1995; Fogoros 2006; 
Morillo and Guzman 2007). Another mechanism is stimulation of the beta-adrenergic 
receptors by anti-beta adrenergic autoantibodies (Chiale et al. 2006).  
5.1.2.4 Natural history: IST is more common in women in the 20s and 30s, who are otherwise 
healthy. It is likely to improve over time (Fogoros 2006). 
5.1.2.5 Clinical presentation: Palpitations, lightheadedness, exercise intolerance, and fatigue 
are common symptoms. Patients may also have orthostatic intolerance, chest pain, anxiety, 
depression, headache and myalgia, gastro-intestinal disturbances, and diaphoresis (Shen 
2005; Fogoros 2006). Only consistent finding on physical exam is tachycardia (Shen 2005; 
Fogoros 2006). 
5.1.2.6 ECG: P-wave morphology and axis is similar to that of normal sinus rhythm (Shen 
2005). There is tachycardia at rest on ECG. 
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5.1.2.7 Diagnosis: Criteria for diagnosis include: a) persistent sinus tachycardia during the 
day with increased rate in response to activity and normalization during sleep per 24-hour 
Holter recording, b) non-paroxysmal tachycardia and symptoms, c) P-wave morphology 
and activation similar to sinus rhythm, and d) exclusion of secondary causes of sinus 
tachycardia (Blomstrom-Lundqvist 2003). 
5.1.2.8 Work-up: In addition to the ECG, a 24-holter monitor will document elevated mean 
heart rates above normal for age, elevated daytime heart rates, and/or exaggerated 
elevation in sinus rate from supine to upright position (Shen 2005). A diagnostic 
electrophysiology (EP) study should be considered if the etiology of the tachycardia is 
unclear (to rule out sinus node re-entry tachycardia). EP study consistent with IST would 
include slow warm up and cool down phases suggesting sinus node involvement, surface P-
wave similar to that of normal sinus rhythm, and earliest activation arising near the sinus 
node area along the crista terminalis during mapping. IST is not initiated with programmed 
stimulation of the atria (Lin and Callans 2004). In addition to electrophysiology testing, there 
is also a need for autonomic dysregulation testing. Neurologic, cardiovascular 
rehabilitation, and psychiatric consultations are often necessary because IST is a diagnosis of 
exclusion (Shen 2005). 
5.1.2.9 Management and Prognosis: Treatment involves a multidisciplinary approach. 
Medications including beta blockers, calcium channel blockers and class IC anti-arrhythmic 
agents decrease SA node automaticity (Chiale et al. 2006). However in patients with IST 
secondary to autonomic dysregulation, control of heart rate does not always lead to 
resolution of symptoms. In patients with no evidence of autonomic dysregulation if 
biofeedback, meditation, and medical therapy fail, superolateral crista terminalis ablation 
could be considered (Shen 2005; Fogoros 2006). Risks of RF ablation include SVC syndrome, 
diaphragmatic paralysis and persistent junctional rhythm. The prognosis of IST is benign 
over a mean follow-up of 6 years (Still et al. 2005). 
5.1.3 Sinus Node Re-entry Tachycardia 
5.1.3.1 Definition: Sino-atrial node re-entry tachycardia (SNRT) is a paroxysmal arrhythmia 
characterized by a re-entry mechanism that is located entirely within the SA node or the 
perisinus atrial tissue (Lin and Callans 2004).  
5.1.3.2 Incidence: Incidence of SNRT is underestimated due to lack of symptoms very often. 
In patients undergoing electrophysiology study for supraventricular tachycardia, incidence 
ranges from 1.8%-16.9% (Blomstrom-Lundqvist 2003). Incidence of SNRT is higher (10%) in 
those with underlying organic heart disease (Garson Jr. and Gillette 1981).  
5.1.3.3 Mechanism: A re-entry mechanism is present but it is not known whether the entire 
circuit is within the SA node or involves perisinus atrial tissue. 
5.1.3.4 Clinical presentation: Patients are often asymptomatic. Symptoms include palpitations, 
lightheadedness, presyncope, and rarely syncope (Gomes et al. 1985). 
5.1.3.5 ECG: SNRT heart rate ranges from 80-200 beats/min. P-wave axis and morphology 
are similar to that of normal sinus rhythm. P-R interval is shorter than R-P interval. An 
atrio-ventricular (AV) nodal Wenckebach block may be present (Olgin and Zipes 2005a). 
5.1.3.6 Diagnosis: Criteria for diagnosis include: a) paroxysmal tachycardia, b) P-wave 
morphology and endocardial atrial activation similar to that of normal sinus rhythm, c) 
inducibility with programmed premature atrial stimuli irrespective of the location of 
stimulation or the AV junction, d) the ability to terminate the arrhythmia with atrial 
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premature beat or atrial pacing, and e) termination with vagal maneuvers or adenosine 
(Narula 1974; Blomstrom-Lundqvist 2003).  
5.1.3.7 Work-up: Electrophysiology study is indicated in patients with frequent and poorly-
tolerated episodes of tachycardia, unclear mechanism of tachycardia, and refractoriness to 
medications.  
5.1.3.8 Management and Prognosis: Vagal maneuvers or adenosine may interrupt the 
tachycardia. Acutely, atrial pacing is effective. Beta blockers, calcium channel blockers, 
amiodarone, and digitalis can benefit patients with increased frequency of symptoms. 
However, prophylactic treatment of SNRT is not recommended. In patients undergoing an 
electrophysiology study, catheter ablation can be successful (Goya et al. 1999).  
5.1.4 Ectopic (focal) Atrial Tachycardia 
5.1.4.1 Definition: Ectopic or focal atrial tachycardia (EAT) is a tachycardia mediated by 
inappropriate atrial impulse generation from a single atrial focus outside of the SA node 
(Walsh 2001a). 
5.1.4.2 Incidence: EAT is commonly found in children and teenagers and makes up 
approximately 15% of all newly diagnosed supraventricular tachycardias across all ages 
(Walsh 2001a). Both genders are equally affected. Prevalence of EAT is 0.34% in 
asymptomatic male patients and 0.46% in symptomatic male patients (Poutiainen et al. 
1999). 
5.1.4.3 Mechanism: EAT can be due to three mechanisms: a) enhanced automaticity, b) 
triggered activity, and c) microreentry (Roberts-Thomson et al. 2006). The tachycardia 
cannot be initiated or terminated with programmed stimuli (Walsh 2001a). However, the 
exact mechanism is difficult to ascertain. 
5.1.4.4 Natural history: In the majority of patients, the course is benign. Persistent incessant 
EAT can lead to ventricular dysfunction, congestive heart failure and low cardiac output 
states, termed tachycardia-mediated cardiomyopathy. However, termination of the rhythm 
can lead to improvement in ventricular function (Packer et al. 1986; Naheed et al. 1995). 
There is slowing of heart rate with time, with reversion to sinus rhythm or change in P-wave 
morphology (Poutiainen et al. 1999). 
5.1.4.5 Clinical presentation: Young patients are often asymptomatic until onset of left 
ventricular dysfunction. Patients may also have palpitations, lightheadedness, and exercise 
intolerance even with normal LV function (Walsh 2001a).  
5.1.4.6 ECG: ECG shows a supraventricular tachycardia with rates within normal range to 
300 beats per minute. ECG criteria for diagnosis include: a) the P-wave morphology and axis 
different than that of normal sinus rhythm, b) acceleration after initiation and deceleration 
before termination, c) unaffected by presence of an atrio-ventricular block, and d) an initial 
P-wave of the tachycardia similar to the subsequent P-waves (Olgin and Zipes 2005a). The 
QRS complex is similar to that of sinus rhythm.  
5.1.4.7 Work-up: The location of the ectopic focus can be determined by noting P-wave 
frontal plane axis. “Warm-up” and “cool-down” patterns can be appreciated and suggestive 
of an automatic mechanism. AV-block (Mobitz 1) can be appreciated episodically during 
sleep. Adenosine administration will demonstrate AV-block with continuous marching of P-
waves (Figure 8). When the ectopic focus is close to the sinus node and/or there is poor 
ventricular function, electrophysiology testing is necessary to differentiate between sinus 
tachycardia, atrial flutter, and ectopic atrial tachycardia. Difficulty to terminate tachycardia 
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with pacing maneuvers and external cardioversion are suggestive of EAT (Walsh 2001a). 
Echocardiography at the time of diagnosis is important to document the ventricular function 
(Naheed et al. 1995).  
5.1.4.8 Management and Prognosis: Paroxysmal and incessant atrial tachycardia are difficult to 
treat medically (Blomstrom-Lundqvist 2003). Acute therapy includes IV verapamil and IV beta 
blockers. There is no termination of tachycardia with atrial pacing, except for mild slowing of 
the heart rate. DC cardioversion is usually not effective but may be effective in those with 
micro-re-entry mechanism. Class IA (e.g. quinidine) and IC (e.g. flecainide, propafenone) anti-
arrhythmics are indicated for those without cardiac failure and Class III (amiodarone) is 
recommended in those with poor ventricular function (Blomstrom-Lundqvist 2003). Chronic 
therapy includes calcium channel blockers, Classes IA, IC, and III anti-arrhythmics; Class IC is 
not indicated in those with coronary artery disease. Intravenous amiodarone or oral sotalol can 
reduce rates and restore sinus rhythm (Skinner and Sharland 2008). Catheter ablation is 
successful in 86-90% with recurrence rate of 8% (Walsh 2001a; Hsieh and Chen 2002). In 
children, 75% had restoration of normal sinus rhythm after medical therapy (Naheed et al. 
1995). In patients with drug refractory EAT or incessant AT with tachycardia-induced 
cardiomyopathy, best option is ablation of the focus (Blomstrom-Lundqvist 2003). Because 
digitalis toxicity can elicit atrial tachycardia, check digitalis levels and avoid hypokalemia. 
 
 
Fig. 8. Ectopic atrial tachycardia with effect of adenosine 
5.1.5 Multifocal (chaotic) Atrial Tachycardia 
5.1.5.1 Definition: Tachycardia characterized by electrocardiographic finding of multiple (at 
least three) distinct P-wave morphologies with irregular P-P intervals, isoelectric baseline 
between P-waves and ventricular rate >100 beats/min (Blomstrom-Lundqvist 2003). 
5.1.5.2 Incidence: MAT is a rare entity. In the pediatric age group, it is reported exclusively in 
neonates and infants, mostly associated with a normal heart (Kastor 1990). It is also 
associated with post-operative congenital heart disease, hypertrophic and dilated 
cardiomyopathies, and unrepaired atrial septal defects (Walsh 2001a). Incidence is 0.2% 
among infants presenting with new onset arrhythmias (Salim et al. 1995). It is associated 
with significant respiratory disease in adults. It is also associated with hypoxemia, glucose 
intolerance, hypokalemia, digitalis, and chronic renal failure (Kones et al. 1974). 
5.1.5.3 Mechanism: Exact mechanism of MAT is unclear; however, automaticity versus 
triggered activity is postulated (Walsh 2001a). 
5.1.5.4 Natural history: Spontaneous resolution may occur in 50-80% of patients with MAT by 
12-18 months of age (Sokoloski 1999). There is no recurrence of MAT in infants with normal 
cardiac structure (Walsh 2001a). 
5.1.5.6 Clinical presentation: Most patients are asymptomatic at the time of detection. If 
tachycardia is persistent, cardiomyopathy develops and symptoms consistent with 
cardiomyopathy arise. 
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5.1.5.7 ECG: Diagnostic criteria include: 1) irregular atrial rates, 2) at least three different P-
wave configurations, 3) isoelectric baseline between discrete P waves, 4) irregular P-P, P-R, 
and R-R intervals, and 5) absence of a dominant atrial pacemaker (Sokoloski 1999). Atrial 
rate may range from 150-500 beats/minute.  
5.1.5.8 Work-up: Meeting ECG criteria is sufficient for diagnosis of MAT (figure 9). 
5.1.5.9 Management and Prognosis: It is usually not responsive to DC cardioversion, vagal 
maneuvers, or IV antiarrhythmics. However, digoxin, beta blockers, amiodarone, and 
flecainide are options to consider. Calcium channel blockers are not indicated in neonates 
and infants less than one year of age. When drug therapy is successful, it should be 
continued for 6-12 months. In rare cases with medication refractory MAT, multiple foci 
ablation is required. In refractory cases, AV node ablation with ventricular pacemaker 
implantation may be necessary (Walsh 2001a). 
 
 
Fig. 9. Multifocal atrial tachycardia 
5.1.6 Atrial flutter 
5.1.6.1 Definition: Atrial flutter is a regular atrial tachycardia due to a macro-reentrant 
rhythm confined to the atrium. There are two types of atrial flutter: 1) typical or Type I and 
2) atypical or Type II. Typical atrial flutter is the most common, cavo-tricuspid isthmus-
dependent, terminated by rapid atrial pacing and is further divided into counter-clockwise 
and clockwise circuits. Atypical atrial flutter has a faster rate (>350 beats/minute), and is not 
cavo-tricuspid isthmus-dependent (Saoudi et al. 2001; Waldo 2004). Left atrial flutter is also 
considered to be atypical (Garan 2008).  
5.1.6.2 Incidence: In a study of 380 patients with first flutter episode between 1 and 25 years 
of life, 81% had congenital heart disease, and 8% had normal hearts (Garson Jr. et al. 1985). 
Among adults, the incidence of atrial flutter overall was 88 per 100,000 person-years with 
male predominance (4:1) and is noted in patients with heart failure, pulmonary disease, 
thyrotoxicosis, post repair of congenital heart defects, and mitral valve disease (Granada et 
al. 2000; Waldo 2004). The incidence of atypical atrial flutter is rare in patients without prior 
cardiac surgery. Atypical right atrial flutter occurs in 8% of patients with atrial flutter (Yang 
et al. 2001). Persistent or recurrent atrial flutter is common in patients post-cardiac surgery 
(Waldo 2004). 
5.1.6.3 Mechanism: The mechanism of atrial flutter is re-entry with an excitable gap, within 
the atrium, right more than left (Waldo 2004). The flutter circuit requires an initially 
activated region to repolarize as the action potential travels through the slow conduction 
tissue and reactivates the initial part, thereby creating a re-entry circuit. The atrial activation 
along the circuit proceeds from the coronary sinus superiorly to the high right atrium area 
and craniocaudally along the free wall and medially to the isthmus between the tricuspid 
valve and the inferior vena cava in a counter-clockwise manner. There is an area of slow 
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conduction in the posteroinferior aspect of the circuit. The clockwise or reverse typical 
circuit proceeds in the opposite direction (Sokoloski 1999).  
5.1.6.4 Natural history: In patients less than one year of age and with no previous cardiac 
surgery, atrial flutter spontaneously converts in 26%. Congestive heart failure was more 
prevalent in those with atrial flutter of long duration. Of the infants with decreased 
ventricular function, all recovered normal function after conversion to sinus rhythm. If 
patients had additional arrhythmia, recurrence of atrial flutter was more likely (Texter et al. 
2006). Atrial flutter persisting over a long period of time can evolve into atrial fibrillation 
(Waldo 2004). 
5.1.6.5 Clinical presentation: In neonates, 80% are asymptomatic and 20% may present with 
congestive heart failure (Texter et al. 2006). Older patients can experience palpitations, 
dizziness, chest tightness, chest pain, shortness of breath, and fatigue. Hypotension, poor 
exercise tolerance, congestive heart failure and impaired cardiac output can also result from 
atrial flutter (Blomstrom-Lundqvist 2003; Andrew and Montenero 2007).  
5.1.6.6 ECG: Counterclockwise (typical) atrial flutter has negative flutter (F) waves in the 
inferior leads II, III, and aVF and positive F waves in Lead V1 (figure 10). Clockwise (reverse 
typical) atrial flutter shows positive F waves in the inferior leads II, III, and aVF and 
negative F waves in lead V1 (Blomstrom-Lundqvist 2003). In typical atrial flutter, P waves 
are absent. The flutter rate can range from 240-340 beats/minute with no isoelectric interval 
between consecutive waves. Flutter rates in infants can be as high as 580 beats/minute with 
rapid ventricular response rates of 200 beats/minute with 2:1 AV conduction in 75% and 
variable block in the remainder (Texter et al. 2006). Flutter waves typically have 90-degree 
axis. The QRS complexes appear normal unless there is rate-dependent aberrancy or block.  
5.1.6.7 Work-up: Echocardiogram is indicated in those with congestive heart failure to 
evaluate ventricular function and structure. 
5.1.6.8 Management and Prognosis: Management of atrial flutter is accomplished through 
electrical cardioversion, rapid atrial pacing, pharmacological therapy, and catheter ablation. 
The goal of flutter management is to decrease the ventricular rate and to restore normal 
sinus rhythm. Chronic anti-arrhythmic therapy may not be needed in those with 
uncomplicated, asymptomatic atrial flutter after conversion to sinus rhythm (Texter et al. 
2006; Skinner and Sharland 2008). Drugs are successful in controlling atrial flutter in about 
58% of young patients. Amiodarone, digoxin, and propranolol are found to be effective 
(Garson Jr. et al. 1985). Atrial flutter causing hemodynamic instability should be terminated 
acutely with electrical cardioversion (2J/Kg) (Class 1 level of evidence) (Blomstrom-
Lundqvist 2003; Texter et al. 2006). Although cardioversion is successful acutely, atrial 
flutter recurs frequently. Recurrences of atrial flutter can be prevented by administering 
Class IA, IC, and III anti-arrhythmic agents. Ventricular rate can be controlled with AV-
nodal blockers such as digitalis and class II (beta blockers), III (amiodarone, sotalol), and IV 
(calcium channel blockers) anti-arrhythmic agents. Flecainide (Class IC anti-arrhythmic) 
should be administered with an AV-node blocking agent. As flecainide slows the atrial rate, 
it may facilitate 1:1 AV conduction, leading to clinical compromise (Skinner and Sharland 
2008). Calcium channel antagonists are contraindicated in children less than one year of age. 
When atrial flutter is refractory to medical management, transesophageal atrial overdrive 
pacing (TEAP) and catheter ablation are excellent options. In a study by Ajisaka (1997), 
paroxysmal atrial flutter was terminated in greater than 50 percent of the adult subjects with 
low-output, short-duration TEAP (Ajisaka et al. 1997). In young adults with repaired 
congenital heart disease, 50-88% had successful ablation of recurrent atrial flutter 
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(Blomstrom-Lundqvist 2003). Catheter ablation is used to create a bidirectional conduction 
block across the cavo-tricuspid isthmus. In addition to palliating with catheter ablation, 
underlying causes of atrial flutter such as stimulants and sympathomimetic agents should 
also be eliminated. 
 
 
Fig. 10. Atrial flutter 
5.1.7 Intra-atrial Reentry Tachycardia 
5.1.7.1 Definition: Intra-atrial reentry tachycardia (IART) is a group of reentry tachycardia 
associated with repaired or unrepaired congenital heart disease (CHD). It is also known as 
slow atrial flutter, incisional atrial tachycardia, and macro-reentrant atrial tachycardia. It is 
very often a long-term complication of cardiac surgery involving the atrium (Triedman 
2001). It is frequently associated with Fontan, Mustard, Senning, repaired tetralogy of Fallot, 
and TAPVR repairs. Risk factors for IART are older age of surgery and long-term follow-up.  
5.1.7.2 Incidence: Incidence of IART often depends on the congenital heart disease and the 
surgery preceding the onset. Structural heart disease is evident in about 89% of patients 
with IART (Haines and DiMarco 1990).  
5.1.7.3 Mechanism: IART has a re-entrant mechanism defined within the atrium and does not 
necessarily follow the atrial flutter circuit. Majority of the reentrant circuits are mainly 
confined to the right atrium (Triedman 2001). 
5.1.7.4 Natural history: IART is intimately associated with atrial fibrillation and thromboembolic 
phenomena. Natural history is associated with increased frequency of recurrences, regardless 
of treatment with anti-arrhythmic medications or ablation (Triedman 2004). Intermediate 
follow-up post ablation of IART shows frequent recurrence with new IART configurations 
(Triedman et al. 1997). 
5.1.7.5 Clinical presentation: Symptoms in patients with IART can range from being 
asymptomatic to congestive heart failure to significant cardiovascular compromise, 
including sudden cardiac death (Triedman 2004). Sinus node dysfunction with symptomatic 
bradycardia is a common association with IART. 
5.1.7.6 ECG: Flutter morphology or uniform P waves are frequently noted with constant 
cycle length longer than typical atrial flutter (figure 11). Multiple ECG morphologies can be 
obtained from a single patient due to various activation mechanisms. There is often 1:1 AV 
conduction based on the cycle length. There is sudden onset and termination with pacing 
and is entrainable (Triedman 2001; Triedman 2004).  
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5.1.7.7 Work-up: In refractory atrial reentry arrhythmias, an electrophysiology study must be 
conducted to further elucidate the nature of the substrate responsible for IART.  
5.1.7.8 Management and Prognosis: Acute management in cardiovascular compromise consists of 
direct current (DC) cardioversion. Other options in clinically stable patients include anti-
arrhythmic medications, atrial overdrive pacing, and anti-tachycardia pacing with pacemakers 
and transesophageal pacing. For chronic therapy, sotalol and amiodarone have been reported 
to be effective in approximately 60% (Triedman 2001). Implanted anti-tachycardia pacemakers 
provide relief from symptomatic tachycardia and bradycardia associated with sinus node 
dysfunction. In cases refractory to medical management, catheter ablation can be attempted. 
Intra-operative surgical Maze procedure is reserved for patients that have failed catheter 
ablation or are scheduled to undergo surgery for another indication. 
 
 
Fig. 11. Intra-atrial re-entrant tachycardia 
6.1 Atrio-Ventricular Reciprocating Tachycardia 
6.1.1 Definition: Atrio-ventricular reciprocating tachycardia (AVRT) is a re-entrant 
tachycardia with an accessory electrical connection between the atrial and ventricular 
myocardium in addition to the AV node (Blaufox and Saul 2001). The accessory pathway 
(AP) can be “concealed” with only retrograde conduction, “manifest” with antegrade or 
bidirectional conduction. The manifestation of antegrade conduction is presence of pre-
excitation with short PR on the electrocardiogram during sinus rhythm suggestive of Wolff-
Parkinson-White (WPW) syndrome. Orthodromic AVRT employs prograde conduction 
through the AV node and bundle of His with retrograde conduction through the AP. 
Antidromic AVRT employs AP for atrio-ventricular conduction with retrograde conduction 
through the bundle of His and AV node. 
6.1.2 Incidence: AVRT is the most common cause of supraventricular tachycardia in children 
without prior cardiac surgery or neuromuscular disease, comprising 73 to 85 percent (Ko et 
al. 1992; Etheridge and Judd 1999). It is more common in infancy compared to AVNRT, the 
incidence of which increases in older children (Ko et al. 1992). Accessory pathways are 
associated with congenital heart defects in 6-26% of the children. The common heart defects 
associated with accessory pathways are Ebstein’s anomaly of the tricuspid valve, ventricular 
inversion (L-TGA), hypertrophic cardiomyopathy, and mitral valve prolapse (Van Hare 
1999). 
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6.1.3 Mechanism: As the name suggests, AVRT has a reentrant mechanism. The reentrant 
mechanism is characterized by an accessory pathway in the left or right atrio-ventricular 
grooves, i.e. extranodal pathway. Atriofascicular and nodofascicular (Mahaim), and 
atrionodal (James) AP are other variants. The left free wall is the most common site of the 
AP, followed by posteroseptal and right free wall AP (Calkins et al. 1999). Even in patients 
with manifest AP, orthodromic narrow complex reciprocating tachycardia is still the most 
common manifestation. 
6.1.4 Natural history: In patients with WPW syndrome with onset less than 2 months of age, 
SVT disappeared in 93% and reappeared in 31% at an average age of 8 years (Perry and 
Garson Jr. 1990). In patients with onset after 5 years of age, seventy eight percent had 
persistence at 7 years of follow-up. Multiple and right-sided AP were more frequent in 
patients with congenital heart disease (Perry and Garson Jr. 1990). Congenital heart defects 
are present in 20 - 37% of patients with WPW (Deal et al. 1985; Perry and Garson Jr. 1990). 
Patients with WPW syndrome are also prone to develop atrial fibrillation with increased 
risk of sudden death (Hare 1999).  
6.1.5 Clinical presentation: Symptoms are usually paroxysmal but may be incessant. 
Symptoms may occur with or without triggers, including activity and exertion. Location, 
rate, duration of tachycardia, and the type of AP very often determine the nature of 
symptoms. Infants tolerate higher rates of tachycardia compared to adolescents and adults. 
Patients perceive sensed tachycardia with or without associated symptoms including 
dizziness, lightheadedness, and mild chest discomfort. Heart failure symptoms with 
orthopnea, paroxysmal nocturnal dyspnea, fatigue, tachypnea, diaphoresis are often present 
in those with persistent tachycardia (Van Hare 1999). Sudden death is attributed to the 
presence of atrial fibrillation with rapid ventricular response across the accessory pathway 
(Van Hare 1999). In orthodromic AVRT, shortness of breath, fatigue, and dizziness are 
common; syncope is less common (Blaufox and Saul 2001). In antidromic AVRT, dizziness, 
syncope, and tendency towards unstable ventricular rhythm are more common than 
orthodromic AVRT (Blaufox and Saul 2001).  
6.1.6 ECG: ECG findings are determined by presence of tachycardia, normal sinus rhythm, 
and type of accessory pathway. In normal sinus rhythm, WPW syndrome is evident by the 
presence of pre-excitation (delta wave) with short PR interval. The pre-excited complex is a 
fusion complex resulting from initial pre-excitation of ventricular myocardium adjacent to 
the AP giving rise to the delta wave, followed by fusion of depolarization of the remainder 
of the ventricular myocardium by normal conduction. In orthodromic AVRT, the QRS 
complexes are narrow due to normal prograde conduction through the AV node and bundle 
of His and retrograde conduction via the AP (figure 12). Orthodromic AVRT have RP 
interval shorter than the PR interval with a P-wave on the upstroke of the T-wave during 
tachycardia, which differentiates it from AVNRT (Van Hare 1999). In antidromic AVRT, the 
QRS complexes are wide due to antegrade conduction down the AP and retrograde 
conduction across the AV node or another AP. AV block terminates the tachycardia due to 
the role of AV node in the tachycardia. WPW is characterized by wide QRS complexes with 
short PR interval. Mahaim AP has pre-excitation with widened QRS complexes but normal 
PR interval and usually manifest as a wide complex tachycardia with left bundle branch 
block pattern. Though the terminology is obsolete, Lown-Ganong-Levine (LGL) syndrome 
has normal QRS complexes with short PR interval.  
6.1.7 Work-up: Baseline ECG during sinus rhythm may show pre-excitation. Depending on 
the frequency of sensed tachycardia or other symptoms, a Holter monitor or a loop recorder 
can be used. Echocardiogram may be obtained to rule out structural heart defects. In 
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patients with pre-excitation, exercise stress test to stratify the risk of sudden catastrophic 
event can be performed. Persistent pre-excitation at peak exercise may suggest a short 
refractory period of the accessory fiber with a higher risk for sudden catastrophic event 
(Blaufox and Saul 2001). To differentiate between narrow complex tachycardias, including 
concealed pathways, AVNRT, and atrial tachycardias, an EP study is required. An EP study 
will also assist in differentiating antidromic AVRT from other wide-complex tachycardias.  
6.1.8 Management and Prognosis: Acute management in patients with significant hemodynamic 
compromise requires synchronized DC cardioversion. Adenosine administration is effective 
and esmolol may be used. Flecainide and procainamide are recommended in pre-excited SVT 
(Blomstrom-Lundqvist 2003). Digoxin and calcium channel blockers are contra-indicated in 
patients with WPW syndrome.  In stable patients, vagal maneuvers may be effective in 
terminating the arrhythmia. Calcium channel blockers are contraindicated in infants. Catheter 
ablation is a class I indication for managing AVRT (Blomstrom-Lundqvist 2003). Left free wall 
AP was predictive of ablation success while right free wall, posteroseptal, septal, and multiple 
APs were predictive of recurrence (Calkins et al. 1999). Medical therapy includes beta blockers 
to block AV node conduction and decrease premature ectopic beats, and class IA, IC, and III 
antiarrhythmics (Triedman 2001).  
 
 
Fig. 12. Orthodromic AV reciprocating tachycardia 
6.2 Atrio-Ventricular Node Reentry Tachycardia 
6.2.1 Definition: Atrio-ventricular node reentry tachycardia (AVNRT) is a re-entry tachycardia 
that is dependent on existence of dual discrete pathways within or in proximity of the AV 
node, one with slow conduction and short effective refractory period and the other with fast 
conduction and long refractory period (Zimmerman 2001; Lockwood et al. 2004). The typical 
ventricular rate in children ranges from 120 to 280 beats/minute (Zimmerman 2001). AVNRT 
is often associated with an accessory pathway. 
6.2.2 Incidence: AVNRT is the most common SVT in adults but consists of 13% of SVT in 
children without underlying heart disease and rarely in children under two years of age (Ko 
et al. 1992). In infants, 15% of SVT was due to AVNRT (Etheridge and Judd 1999). 
6.2.3 Mechanism: Dual AV node physiology is present in 33-35% of the children without 
clinical or inducible AVNRT in congenital or acquired heart disease (Casta et al. 1980). The 
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“slow-fast” or typical form of the AVNRT is the most common form. A premature atrial or 
junctional beat blocks the fast pathway with subsequent antegrade conduction through the 
slow pathway. If the fast pathway recovers as the impulse conducts through the slow 
pathway, the substrate for reentry is present. In the less common “fast-slow” or atypical 
form of AVNRT, the premature atrial impulse is blocked in the slow pathway and is 
conducted antegrade along the fast pathway. If the slow pathway recovers, a reentry 
substrate is present; antegrade conduction down the fast pathway and retrograde 
conduction up the slow pathway is present (Zimmerman 2001). The least common form is 
the “slow-slow” dual node physiology. There is retrograde atrial activation with early atrial 
activation in the low right atrium, followed by left and remaining right atrial activation 
(Olgin and Zipes 2005a). 
6.2.4 Natural history: AVNRT is not life-threatening and patients with minimal symptoms do 
well without therapy. Female patients are more symptomatic and tend to present with 
syncope (Drago et al. 2006).  
6.2.5 Clinical presentation: Symptoms include palpitations, chest pain, heart failure, and 
shock, and rarely syncope, dependent on the duration of the AVNRT. Tachycardia is 
paroxysmal. 
6.2.6 ECG: AVNRT is a regular narrow QRS complex tachycardia with abrupt onset and 
termination. The QRS complex may appear wider in case of baseline bundle branch block or 
rate dependent aberrant conduction. There is no pre-excitation appreciated during normal 
sinus rhythm in sole AVNRT. In slow-fast AVNRT, retrograde P-waves are not appreciated 
and are located within the terminal part of the QRS complexes. In fast-slow AVNRT, the P 
waves have a superior axis with RP interval longer than PR interval. 
6.2.7 Work-up: An electrophysiology study is indicated to definitively establish the diagnosis 
of AVNRT and dual AV node physiology. 
6.2.8 Management and Prognosis: Management of AVNRT is based on the frequency and the 
symptoms during the episodes. In those with infrequent, asymptomatic episodes, no 
treatment is necessary. Paroxysmal episodes may be terminated with Valsalva maneuver or 
carotid sinus massage. In acute decompensation, DC synchronized cardioversion, 
adenosine, IV beta blockers or digoxin can be employed (Zimmerman 2001). In patients with 
infrequent episodes desiring complete control, ablation is recommended. Patients with 
recurrent AVNRT refractory to beta blockers and calcium channel blockers, flecanide and 
sotalol are class IIA recommendations. In recurrent, symptomatic patients with significant 
side effects of medications and those with poorly tolerated AVNRT, catheter ablation of the 
slow AV nodal pathway is suggested (Blomstrom-Lundqvist 2003).  
7. Junctional Tachy-arrhythmias 
7.1 Junctional Ectopic Tachycardia 
7.1.1 Definition: Junctional ectopic tachycardia (JET), also called junctional automatic 
tachycardia, is an incessant tachycardia characterized by rapid heart rate with the focus of 
abnormal automaticity in the junction. Ventricular rates in patients with JET ranges from 
140-370 beats/minute (Villain et al. 1990). 
7.1.2 Incidence: Incidence of JET occurs in two cohorts: neonatal and post-operative patients. 
Congenital JET occurs in the first six months of life and a family history is usually present 
(Sarubbi et al. 2002). Overall, JET occurs in 1% of congenital heart repairs (Walsh 2001a). JET 
occurred in 22% of Tetralogy of Fallot (TOF) repairs, 10% of atrio-ventricular septal defect 
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repairs, and 3.7% of VSD repairs (Dodge-Khatami et al. 2002). Predictors of post-operative 
JET were younger age (Hoffman et al. 2002), lower body weight (Rekawek et al. 2007), 
resection of muscle bundles, higher bypass temperatures, and relief of right ventricular 
outflow tract obstruction through the right atrium (Dodge-Khatami et al. 2002).  
7.1.3 Mechanism: Although the mechanism of JET is unclear, abnormal (enhanced) 
automaticity of the junction has been put forth. In post-operative congenital heart disease 
patients, it is hypothesized that direct trauma or infiltrative hemorrhage of the conduction 
system leads to enhanced automaticity of the His bundle (Dodge-Khatami et al. 2002).  
7.1.4 Natural history: Congenital JET is associated with high mortality, most of which is 
attributed to sudden cardiac death (Villain et al. 1990). Concurrent arrhythmias may co-exist 
with JET, such as complete heart block, ventricular tachycardia, and persistent junctional 
reciprocating tachycardia. Post-operative JET is a transient state lasting on average 36 hours 
(Walsh 2001a) and is associated with higher mortality and longer intensive care unit (ICU) 
stay (Andreasen et al. 2008).  
7.1.5 Clinical presentation: Congenital JET presents with cardiomegaly with concomitant heart 
failure in more than 50 percent, death in 35 percent (Villain et al. 1990), hydrops fetalis, and 
echocardiographic evidence of left ventricular dysfunction. In post-operative JET, the 
decreased ventricular filling time leads to cardiovascular compromise. 
7.1.6 ECG: ECG criteria include 1) QRS morphology similar to that of sinus rhythm, 2) rapid 
ventricular rate, and 3) dissociated sinus rhythm with atrial rate often less than ventricular 
rate or retrograde 1:1 conduction (Walsh 2001a). If variability exists in R-R interval, 
appropriately timed P-waves may conduct to the ventricular tissue (Figure 13). 
 
 
Fig. 13. Junctional ectopic tachycardia 
7.1.7 Work-up: An electrophysiology study is generally not necessary in patients with JET, 
unless ablation is being considered for medication-refractory symptoms (Walsh 2001a). In 
cases of 1:1 retrograde conduction across the AV node, adenosine can clarify the underlying 
rhythm by blocking the AV node. 
7.1.8 Management and Prognosis: Management of post-operative JET includes achievement of 
AV synchrony and rate control. Atrial pacing above the rate of JET may establish rate control 
(Walsh 2001a). Post-operative JET is generally responsive to intravenous amiodarone, a class 
III antiarrhythmic (Shah and Rhodes 1998). Mean length of time for termination of post-
operative JET after loading and infusion of amiodarone was 4.5 hours with majority achieving 
control within 12 hours (Plumpton et al. 2005). Decreasing the body core temperature to 32-34 
°C, decreasing the sympathomimetic catecholamine levels, optimizing volume, electrolytes 
and hemoglobin contribute to decreased ventricular rate by decreasing the automaticity 
(Cabrera et al. 2002). Magnesium supplementation has been shown to be beneficial in 
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prevention of post-operative JET (Dorman et al. 2000). JET is unresponsive to DC 
cardioversion, overdrive pacing, and programmed atrial or ventricular stimulation (Sarubbi et 
al. 2003). Pharmacologic treatment of congenital JET with monotherapy is less successful than 
combined therapy with amiodarone, digoxin or class IA medication (Sarubbi et al. 2002). 
Patients with drug-refractory congenital JET should undergo catheter ablation with 
maintenance of the normal atrio-ventricular conduction (Walsh 2001a). A pacemaker is 
recommended in those children with evidence of impaired conduction with atrial stimulation, 
sinus dysfunction, or spontaneous AV block on ECG or Holter monitor (Walsh 2001a).  
7.2 Persistent Junctional Reciprocating Tachycardia 
7.2.1 Definition: Persistent or permanent junctional reciprocating tachycardia (PJRT) is an 
incessant tachycardia characterized by prograde conduction through the AV node and 
retrograde conduction through a slow accessory pathway located in the posteroseptal (74%) 
region with decremental conduction properties (Critelli, G. et al. 1984; Lindinger, A. et al. 
1998; Vaksmann, G. et al. 2006). PJRT is a narrow complex tachycardia with rates ranging 
from 120-250 beats/min and infants having higher tachycardia rates than children 
(Dorostkar et al. 1999). 
7.2.2 Incidence: PJRT consists of 1% to 6% of all supraventricular tachycardia (Dorostkar et al. 
1999; Blaufox and Saul 2001). It can present in infancy and into early childhood. 
7.2.3 Mechanism: PJRT has a reentrant mechanism with accessory pathways which are 
mostly isolated and in patients without congenital heart disease (Vaksmann, G et al. 2006).  
7.2.4 Natural history: In a recent study by Vaksmann et al (2006), PJRT resolved 
spontaneously in 22 percent (Vaksmann, G et al. 2006). Long term persistence of PJRT can 
lead to tachycardia-mediated cardiomyopathy, which resolves with appropriate rate control 
(Lindinger, A et al. 1998; Noe et al. 2002). Uncontrolled PJRT may lead to death. 
7.2.5 Clinical presentation: Patients often are asymptomatic in childhood. Symptomatic 
patients present with intermittent palpitations, exercise intolerance, and syncope (Dorostkar 
et al. 1999).  
7.2.6 ECG: ECG shows retrograde P-wave in leads II, III, aVF, and left lateral leads, and R-P 
interval longer than P-R interval (Dorostkar et al. 1999). The long R-P interval is attributed 
to the slow retrograde conduction. In sinus rhythm, there is no delta wave and P-R interval 
is normal (Critelli, G et al. 1984). QRS complexes are narrow. 
7.2.7 Work-up: PJRT is likely under-diagnosed in childhood and patients present with heart 
failure with associated ventricular dysfunction. An ECG and Holter monitor should be 
considered. An echocardiogram should be performed to assess the cardiac function and 
structure and serial echocardiograms are necessary in those with depressed LV function. An 
electrophysiology study and catheter ablation may be performed in refractory PJRT 
associated with decreased ventricular function (Dorostkar et al. 1999). 
7.2.8 Management and Prognosis: Many patients with stable infrequent episodes and slow 
tachycardia may not require medical therapy (Lindinger, A et al. 1998). In pediatric patients, 
amiodarone and verapamil alone had success rates of 84-94% (Vaksmann, G et al. 2006). 
Digoxin alone had a success rate of 50%. Hence, medical therapy with anti-arrhythmic drugs 
should be advocated prior to consideration of catheter ablation (Drago et al. 2001). Pediatric 
and adult patients with medication-refractory incessant PJRT should undergo direct current 
catheter ablation, with good safety and efficacy (Aguinaga et al. 1998).  
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8.1 Ventricular Tachycardia 
8.1.1 Definition: Ventricular tachycardia (VT) is a tachycardia with rates greater than 120 
beats per minute and originating within the ventricles or the lower conduction system with 
ventriculo-atrial dissociation. Non-sustained VT is defined as a three or more consecutive 
beats of ventricular origin that terminate spontaneously with no hemodynamic compromise 
and lasting less than 30 seconds. Sustained VT persists longer than 30 seconds or requires 
medical or electrical intervention to terminate the tachycardia (AHA 2007).  
8.1.2 Incidence: In healthy teenage boys, short episodes of ventricular tachycardia were 
present in 3% (Dickinson and Scott 1984). Incidence of VT is higher in patients with 
congenital heart disease. Approximately 30% of post-operative tetralogy of Fallot patients 
had sustained monomorphic VT and 4.4% had polymorphic VT, which contributes to 2% 
annual risk of sudden cardiac death (Khairy et al. 2004; Walsh, E. and Cecchin, F. 2007). VT 
originates in the RVOT in 60%-80% of structurally normal hearts (Lerman et al. 2004). 
Idiopathic VT is also associated with aortic valve disease, corrected transposition of the 
great arteries, Ebstein’s anomaly of the tricuspid valve, Eisenmenger’s syndrome, long QT 
syndrome, unrepaired tetralogy of Fallot, arrhythmogenic right ventricular dysplasia, and 
myocardial infarction (Callans, D. and Josephson, M. 2004; Fontaine et al. 2004; Walsh, E. P. 
and Cecchin, F. 2007).  
8.1.3 Mechanism: Ventricular tachycardia characterized by a re-entry mechanism can be 
initiated and terminated with programmed stimuli (Callans, D and Josephson, ME 2004). VT 
may also be secondary to automaticity or triggered activity. 
8.1.4 Natural history: Post-operative congenital heart disease patients are at high risk of VT 
and sudden cardiac death. In patients with normal hearts, younger children (90%) and older 
populations (50%-70%) have resolution of VT within 2 to 10 years (Alexander 2001b). 
However, symptomatic younger patients had worse prognosis (Davis et al. 1996). In patients 
with normal intracardiac anatomy, only 50% have an actual diagnosis such as hypertrophic 
cardiomyopathy, dilated cardiomyopathy, myocarditis, myocardial hamartoma, and 
metabolic disease (Davis et al. 1996). Ventricular tachycardia is present in 50%-60% of 
patients with dilated cardiomyopathy and responsible for 8%-50% of deaths (Galvin and 
Ruskin 2004). 
8.1.5 Clinical presentation: Clinical presentation is variable (Davis et al. 1996). Symptoms may 
range from palpitations, light headedness, syncope, shortness of breath, neck fullness, and 
chest pain to death (Silka and Garson Jr. 1999). 
8.1.6 ECG: Monomorphic VT is a wide complex tachycardia with same QRS morphology, 
which suggests a single re-entrant focus (figure 14). Polymorphic VT is a wide complex 
tachycardia with variable QRS morphology. Torsades de pointe is a form of polymorphic 
VT and associated with long QT syndrome and variable electrical activation. (Figure 15) 
8.1.7 Work-up: Obtain a thorough personal and family history including history of sudden 
cardiac death. An ECG of the arrhythmia is useful but very difficult to capture very often; 
however, a resting ECG is a class 1 recommendation (Zipes and Camm 2006). Check 
electrolytes, in particular hypokalemia, hyperkalemia, and hypomagnesemia. In patients 
with recurrent syncope, a holter monitor or event recorder is indicated. An echocardiogram 
is necessary to identify structural heart disease and evaluate cardiac function in those at risk 
for sudden cardiac death such as dilated, hypertrophic, and arrhythmogenic RV dysplasia, 
myocarditis, and inherited disorders (Zipes and Camm 2006). An exercise stress test is 
indicated in all individuals, regardless of age, known or suspected to have exercise-induced 
ventricular tachycardia. An electrophysiology study is warranted in patients with 
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congenital/structural heart disease, those with unknown etiology of VT, and those with 
syncope of unknown etiology with LV dysfunction (Zipes and Camm 2006).  
8.1.8 Management and Prognosis: All wide complex tachycardias need to be treated like 
ventricular tachycardia unless proven otherwise. A-V dissociation, superior QRS axis and 
positive or negative concordance of QRS complexes in the precordial leads suggest 
ventricular origin. In patients with normal hearts, episodes of non-sustained VT has good 
prognosis. Avoid medications that prolong QT interval and correct electrolyte 
abnormalities. In patients with sustained VT with hemodynamic compromise, direct current 
(DC) cardioversion is indicated (Zipes and Camm 2006). In stable monomorphic VT, IV 
procainamide or amiodarone, and/or transvenous catheter pace termination maybe 
employed. In patients with polymorphic VT, DC cardioversion, IV amiodarone and beta 
blockers maybe employed. Internal cardiac defibrillator is indicated in patients with 
congenital heart disease who have survived cardiac arrest, patients with severely impaired 
ventricular function, and those on chronic optimal medical therapy with a life expectancy of 
at least one year (Zipes and Camm 2006). 
 
 
 
 
Fig. 14. Ventricular tachycardia 
 
 
 
Fig. 15. Torsades de pointe 
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